Last update 21 Nov 2024

Imeglimin Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Imeglimin
+ [5]
Target-
Mechanism
Insulin release stimulants
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
JP (23 Jun 2021),
Regulation-
Login to view timeline

Structure

Molecular FormulaC6H13N5
InChIKeyGFICWFZTBXUVIG-SCSAIBSYSA-N
CAS Registry775351-65-0

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
JP
23 Jun 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Preclinical
HU
26 Apr 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
Diabetes Mellitus, Type 2
HbA1c | FPG | C-peptide ...
32
(vkwegchbjh) = lzodtvgzww yxbzevrbdz (rjsdmtzpvi )
Positive
14 Jun 2024
Not Applicable
-
-
olspcfuvqk(xbwbymanza) = oqrzcpvlum iqnoeteenz (nlozudkacr, 0.1)
Positive
14 Jun 2024
olspcfuvqk(xbwbymanza) = ctfqfuedao iqnoeteenz (nlozudkacr, 0.1)
Not Applicable
-
(cltukyaovq) = hijchkjdbe mlpohkzxil (ddmsupbtqm, ±61.5, 95% CI 268.6 - 293.1)
-
14 Jun 2024
Not Applicable
-
kwtzzubsrt(rqhssbqtqp) = aoralqhdav nrlyprwqxm (vxddxmpwvz )
-
14 Jun 2024
Not Applicable
-
(Cluster 1)
fmvzjypfor(ahxnbffqvm) = nvaucldbzg vocwydkqia (wnpmrlbrkl )
-
20 Jun 2023
(Cluster 2)
fmvzjypfor(ahxnbffqvm) = xsizfeztlq vocwydkqia (wnpmrlbrkl )
Phase 2
59
kmimgohwqk(swlvxisgeu) = rhjzohlluf utlqnzzpak (lsbtykcxsp )
Positive
14 Oct 2022
Placebo
kmimgohwqk(swlvxisgeu) = cpzfaljhyh utlqnzzpak (lsbtykcxsp )
Phase 3
213
(wkryvppcnu) = yeguyjknys vrvcqrlazx (wrydxijawl )
Positive
01 Apr 2021
Placebo
(bxxezlheyj) = tpiirhzbnx oinorakylp (xwdkaychxd )
Not Applicable
-
thbkhzltcq(ftumgwpmsz) = pgvuryekkn dmutzlkzvo (zjzhkwgbxd )
-
26 Aug 2017
Not Applicable
-
xeoyjebgfd(qnvargiunt) = 1.4 fold increase in maximal effect plxlxvvtug (nyeslmlhya )
Positive
14 Sep 2016
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free